Irene Somerville, DPT | |
476 N Greenbush Rd Ste 3, Rensselaer, NY 12144-9424 | |
(518) 326-3771 | |
(518) 776-1070 |
Full Name | Irene Somerville |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 6 Years |
Location | 476 N Greenbush Rd Ste 3, Rensselaer, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023598992 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pelvis Spine And Sport Physical Therapy Llc | 6002159001 | 4 |
News Archive
Young people have a more robust immune response to the loss of a loved one, according to new research from the University of Birmingham, providing insight into how different generations cope with loss.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
New research investigating neurological decline in a population of "super healthy" elderly subjects found that the decline in neurological function of the peripheral nervous system attributed to aging may be related to metabolic factors, such as blood sugar levels, even if these factors are within the normal range.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers.
› Verified 7 days ago
Provider Name | Pelvis Spine & Sport Physical Therapy Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1699235564 PECOS PAC ID: 6002159001 Enrollment ID: O20190514002902 |
News Archive
Young people have a more robust immune response to the loss of a loved one, according to new research from the University of Birmingham, providing insight into how different generations cope with loss.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
New research investigating neurological decline in a population of "super healthy" elderly subjects found that the decline in neurological function of the peripheral nervous system attributed to aging may be related to metabolic factors, such as blood sugar levels, even if these factors are within the normal range.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Irene Somerville, DPT 476 N Greenbush Rd Ste 3, Rensselaer, NY 12144-9424 Ph: (518) 326-3771 | Irene Somerville, DPT 476 N Greenbush Rd Ste 3, Rensselaer, NY 12144-9424 Ph: (518) 326-3771 |
News Archive
Young people have a more robust immune response to the loss of a loved one, according to new research from the University of Birmingham, providing insight into how different generations cope with loss.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
New research investigating neurological decline in a population of "super healthy" elderly subjects found that the decline in neurological function of the peripheral nervous system attributed to aging may be related to metabolic factors, such as blood sugar levels, even if these factors are within the normal range.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers.
› Verified 7 days ago
Amber M Thornton, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2 Empire Dr Ste 202, Rensselaer, NY 12144 Phone: 518-286-4990 | |
Jon Paul Van Kempen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Agway Dr, Rensselaer, NY 12144 Phone: 518-326-9065 Fax: 518-326-9064 | |
Stefanie L Walsh, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Empire Dr Ste 202, Rensselaer, NY 12144 Phone: 518-286-4990 | |
Lori Costanzo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Empire Dr, Rensselaer, NY 12144 Phone: 518-286-4990 Fax: 518-286-4988 | |
Kruti B Shah, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 56 Haywood Ln, Rensselaer, NY 12144 Phone: 973-234-7843 | |
Suzanne Debauche, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Empire Dr, Rensselaer, NY 12144 Phone: 518-286-4990 Fax: 518-286-4988 |